The Erythropoietin Drugs Market Is Predicted To Reach USD 14.32 Billion With A CAGR Of 9.7% According To Market Data Forecast Report.

The Erythropoietin Drugs Market Is Predicted To Reach USD 14.32 Billion With A CAGR Of 9.7% According To Market Data Forecast Report.

ID: 6786 | October 2018 | Region: Global


The Erythropoietin Drugs Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Erythropoietin Drugs Market is estimated to be USD 9.06 billion in 2017 and predicted to rise to USD 14.32 billion by 2022 with a CAGR of 9.7%. The market is segmented by product ( Epoetin-alpha, epoetin-beta, darbepoetin-alfa and others) , by application ( cancer, hematology, renal diseases and neurology) , by drug class ( biologics and biosimilar). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

Increased incidence of anemia, rising commercialization of EPO drugs and favorable reimbursement policies are further driving the market growth. As cheaper biosimilars are also available the market is expected to propel during the forecast period.

The market for Erythropoietin Drugs is broadly categorized into product, application and drug class. By product the market is divided into Epoetin-alpha, epoetin-beta, darbepoetin-alfa and others. Epoietin-alfa holds the largest market share. By application the market is classified into cancer, hematology, renal diseases and neurology. Cancer segment is predicted to be fastest growing segment. By drug class the market is segmented into biologics and biosimilar. Biosimilars are predicted to grow at a significant rate during the forecast period.

On the basis of geography, the market is analyzed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Erythropoietin Drugs market was dominated by Europe followed closely by North America. Asia Pacific is expected to grow at a high CAGR.

Some of the major companies dominating the market, by their products and services include Johnson & Johnson, Celltrion, Inc, Teva Pharmaceutical Industries Ltd. , Sun Pharmaceutical Industries Ltd. , Dr. Reddy’s Laboratories Ltd.Amgen, Inc. , F. Hoffmann-La Roche Ltd. , LG Life Sciences Ltd. , Biocon Limited  and Intas Pharmaceuticals Ltd.

Browse through the full report at “https://www.marketdataforecast.com/market-reports/erythropoietin-drugs-market-6767/” and checkout our recent reports in the Pharmaceuticals category at “https://www.marketdataforecast.com/subcategory/pharmaceuticals-1/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.